Natural products that target p53 for cancer therapy

被引：0
作者：
Tsukamoto, Sachiko [1 ]
机构：
[1] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Nat Med, 5-1 Oe Honmachi, Kumamoto 8620973, Japan
来源：
JOURNAL OF NATURAL MEDICINES | 2025年 / 79卷 / 04期
基金：
日本学术振兴会;
关键词：
Natural products; p53; reactivation; Tumor suppressor; Cancer therapy; SULFONATED SERINOL DERIVATIVES; UBIQUITIN-ACTIVATING ENZYME; POTENT CYTOTOXIC MACROLIDE; MARINE-DERIVED FUNGUS; MUTANT P53; MULTIDRUG-RESISTANCE; PROTEASOME INHIBITOR; MDM2; INHIBITOR; STEROL ACETATE; SWINHOLIDE-A;
D O I：
10.1007/s11418-025-01906-6
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Wild-type p53 acts as a tumor suppressor, but p53 is frequently mutated and inactivated in tumor cells, promoting cancer progression, invasion, and metastasis. Thus, compounds that reactivate p53 may be leveraged for cancer treatment, and the development of drugs targeting p53 reactivation is actively progressing. Notably, natural products exhibit diverse structures and biological activities and are used as therapeutic agents for various diseases worldwide. This review discusses the natural products that inhibit p53 degradation through p53-Mdm2 interaction, promote p53 reactivation by inducing conformational changes, and exhibit p53-dependent growth inhibition.
引用
收藏
页码：725 / 737
页数：13
相关论文
共 79 条
[1]   Potential for proteasome inhibition in the treatment of cancer [J].
Adams, J .
DRUG DISCOVERY TODAY, 2003, 8 (07) :307-315
[2]   Reactivation of mutant p53 by a dietary-related compound phenethyl isothiocyanate inhibits tumor growth [J].
Aggarwal, M. ;
Saxena, R. ;
Sinclair, E. ;
Fu, Y. ;
Jacobs, A. ;
Dyba, M. ;
Wang, X. ;
Cruz, I. ;
Berry, D. ;
Kallakury, B. ;
Mueller, S. C. ;
Agostino, S. D. ;
Blandino, G. ;
Avantaggiati, M. L. ;
Chung, F-L .
CELL DEATH AND DIFFERENTIATION, 2016, 23 (10) :1615-1627
[3]   Mutant p53 Gain-of-Function: Role in Cancer Development, Progression, and Therapeutic Approaches [J].
Alvarado-Ortiz, Eduardo ;
de la Cruz-Lopez, Karen Griselda ;
Becerril-Rico, Jared ;
Sarabia-Sanchez, Miguel Angel ;
Ortiz-Sanchez, Elizabeth ;
Garcia-Carranca, Alejandro .
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 8
[4]  
[Anonymous], about us
[5]   Agosterol A, a novel polyhydroxylated sterol acetate reversing multidrug resistance from a marine sponge of Spongia sp. [J].
Aoki, S ;
Yoshioka, Y ;
Miyamoto, Y ;
Higuchi, K ;
Setiawan, A ;
Murakami, N ;
Chen, ZS ;
Sumizawa, T ;
Akiyama, S ;
Kobayashi, M .
TETRAHEDRON LETTERS, 1998, 39 (35) :6303-6306
[6]   Reversing effect of agosterol A, a spongean sterol acetate, on multidrug resistance in human carcinoma cells [J].
Aoki, S ;
Chen, ZS ;
Higasiyama, K ;
Setiawan, A ;
Akiyama, S ;
Kobayashi, M .
JAPANESE JOURNAL OF CANCER RESEARCH, 2001, 92 (08) :886-895
[7]   Regulation of p53 stability [J].
Ashcroft, M ;
Vousden, KH .
ONCOGENE, 1999, 18 (53) :7637-7643
[8]   Natural products in drug discovery: advances and opportunities [J].
Atanasov, Atanas G. ;
Zotchev, Sergey B. ;
Dirsch, Verena M. ;
Supuran, Claudiu T. .
NATURE REVIEWS DRUG DISCOVERY, 2021, 20 (03) :200-216
[9]   TP53 Variations in Human Cancers: New Lessons from the IARC TP53 Database and Genomics Data [J].
Bouaoun, Liacine ;
Sonkin, Dmitriy ;
Ardin, Maude ;
Hollstein, Monica ;
Byrnes, Graham ;
Zavadil, Jiri ;
Olivier, Magali .
HUMAN MUTATION, 2016, 37 (09) :865-876
[10]   When mutants gain new powers: news from the mutant p53 field [J].
Brosh, Ran ;
Rotter, Varda .
NATURE REVIEWS CANCER, 2009, 9 (10) :701-713
12345678